micro-community-banner
 
  • Saved

Population Pharmacokinetics of Belantamab Mafodotin, a BCMA-targeting Agent in Patients with Relapsed/Refractory Multiple Myeloma - PubMed

Population Pharmacokinetics of Belantamab Mafodotin, a BCMA-targeting Agent in Patients with Relapsed/Refractory Multiple Myeloma - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34076364/

Belantamab mafodotin (belamaf) is an antibody-drug conjugate (ADC) targeting B-cell maturation antigen (BCMA). Nonlinear mixed-effects models were developed to characterize the population pharmacokinetics (PopPK) of ADC, total monoclonal antibody (mAb),...

  • Saved

Review of Venetoclax in CLL, AML and Multiple Myeloma - PubMed

Review of Venetoclax in CLL, AML and Multiple Myeloma - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34073976/

Venetoclax is a highly selective and effective B-cell lymphoma-2 (BCL-2) inhibitor, which is able to reinstate the apoptotic potential of cancer cells. With its full repertoire yet to be explored,...

  • Saved

KDM2A Targets PFKFB3 for Ubiquitylation to Inhibit the Proliferation and Angiogenesis of Multiple Myeloma Cells - PubMed

KDM2A Targets PFKFB3 for Ubiquitylation to Inhibit the Proliferation and Angiogenesis of Multiple Myeloma Cells - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34079757/

The lysine demethylase KDM2A (also known as JHDM1A or FBXL11) demethylates histone H3 at lysine K36 which lead to epigenetic regulation of cell proliferation and tumorigenesis. However, many biological processes...

  • Saved

Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial - PubMed

Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34078314/

doi: 10.1186/s12885-021-08325-2. 1 Department of Haematology and Oncology, Würzburg University Medical Center, Oberdürrbacher Straße 6, 97080, Würzburg, Germany. [email protected]. 2 University Hospital of Salamanca-Instituto de Investigación Biomédica de Salamanca, Salamanca,...

  • Saved

Propensity-score matched analysis of the efficacy of maintenance/continuous therapy in newly diagnosed patients with multiple myeloma: a multicenter retrospective collaborative study of the Japanese Society of Myeloma - PubMed

Propensity-score matched analysis of the efficacy of maintenance/continuous therapy in newly diagnosed patients with multiple myeloma: a multicenter retrospective collaborative study of the Japanese Society of Myeloma - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34080068/

doi: 10.1007/s00432-021-03668-6. Online ahead of print. 1 Department of Hematology, Tokushima Prefectural Central Hospital, 1-10-3 Kuramoto, Tokushima, 770-8539, Japan. [email protected]. 2 Department of Hematology, Gunma University Graduate School of Medicine,...